At $547.86 apiece, a director sold 271 Vertex Pharmaceuticals (VRTX) shares.
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
Vertex Pharmaceuticals Inc. (VRTX) director Sangeeta N. Bhatia sold 271 shares of common stock at $547.86 per share on November 16, 2026. This transaction was executed under a Rule 10b5-1 trading plan established on August 13, 2026. Following the sale, Dr. Bhatia directly holds 4,653 shares of the company.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.